Then, the R2 gene database was used to analyse the relationship between TRIP13 expression and patient prognosis, and the results showed that high expression of TRIP13 was associated with poor prognosis in GBM patients (Fig. 1c). This evidence concerns the gene TRIP13 and glioblastoma.